Overview

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of After Administrations of DWP14012 Alone and Combinations of DWP14012, Clarithromycin and Amoxicillin in Healthy Male Subjects

Status:
Completed

Trial end date:
2019-01-11

Target enrollment:

Participant gender:

Summary

This is a randomized, open-label, multiple dose, two-part phase I clinical trial to compare the pharmacokinetics, pharmacodynamics and safety/tolerability of DWP14012 after administrations of DWP14012 alone and combinations of DWP14012, Clarithromycin and Amoxicillin in healthy male subjects

Phase:

Phase 1

Details

Lead Sponsor:

Daewoong Pharmaceutical Co. LTD.

Treatments:

Amoxicillin
Clarithromycin
Dexlansoprazole
Lansoprazole